John D Kirsch

Title: John D. Kirsch: Innovator in Pharmaceutical Compositions

Introduction

John D. Kirsch is a notable inventor based in Waynesburg, PA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of solid oral pharmaceutical compositions. His work focuses on enhancing the safety and efficacy of medications through innovative formulations.

Latest Patents

John D. Kirsch holds a patent for a solid oral pharmaceutical composition that includes alkyl 3,4,5-trihydroxybenzoate as a nitrosamine inhibitor. This invention relates to a composition that comprises an active pharmaceutical ingredient, a nitrosamine inhibitor, and a pharmaceutically acceptable excipient. The nitrosamine inhibitor is designed to reduce the formation of nitrosamines, which can be harmful, thereby improving the safety profile of the pharmaceutical composition.

Career Highlights

Kirsch is associated with Mylan Pharmaceuticals Inc., a leading global generic and specialty pharmaceuticals company. His work at Mylan has allowed him to contribute to the development of innovative pharmaceutical solutions that address critical health needs. His expertise in pharmaceutical formulations has positioned him as a valuable asset in the industry.

Collaborations

John D. Kirsch has collaborated with Ross A. Friedman, working together to advance pharmaceutical innovations. Their partnership has focused on developing effective solutions that enhance drug safety and efficacy.

Conclusion

John D. Kirsch's contributions to pharmaceutical compositions highlight his commitment to improving medication safety through innovative formulations. His work continues to impact the pharmaceutical industry positively.